Savant Capital LLC Boosts Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Savant Capital LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 17.8% during the 4th quarter, Holdings Channel.com reports. The firm owned 6,803 shares of the medical equipment provider’s stock after acquiring an additional 1,030 shares during the period. Savant Capital LLC’s holdings in Intuitive Surgical were worth $3,551,000 as of its most recent filing with the SEC.

Other hedge funds also recently added to or reduced their stakes in the company. M.E. Allison & CO. Inc. purchased a new stake in Intuitive Surgical in the fourth quarter valued at $449,000. Seilern Investment Management Ltd acquired a new position in shares of Intuitive Surgical in the fourth quarter worth about $82,517,000. Exome Asset Management LLC raised its position in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after acquiring an additional 1,069 shares during the period. China Universal Asset Management Co. Ltd. raised its position in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after acquiring an additional 525 shares during the period. Finally, Consolidated Planning Corp raised its position in shares of Intuitive Surgical by 17.4% in the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after acquiring an additional 1,198 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jamie Samath sold 269 shares of the stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the sale, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at approximately $1,936,380. This trade represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 6,348 shares of company stock worth $3,587,582. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 0.7 %

ISRG stock opened at $591.65 on Wednesday. The company has a market cap of $210.73 billion, a price-to-earnings ratio of 92.30, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The firm has a 50-day moving average of $555.91 and a two-hundred day moving average of $515.92.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. BTIG Research upped their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Bernstein Bank upped their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Royal Bank of Canada upped their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Stifel Nicolaus upped their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Finally, Truist Financial upped their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.